These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Cardiac surgery in a patient with retroperitoneal fibrosis and heart valvulopathy, both due to pergolide medication for Parkinson's disease. Apostolakis EE; Baikoussis NG; Tselikos D; Koniari I; Prokakis C; Fokaeas E; Karanikolas M J Cardiothorac Surg; 2009 Nov; 4():65. PubMed ID: 19912629 [TBL] [Abstract][Full Text] [Related]
11. [Organ changes induced by ergot derivative dopamine agonist drugs: time to change treatment guidelines in Parkinson's disease?]. Roth J; Ulmanová O; Růzicka E Cas Lek Cesk; 2005; 144(2):123-6. PubMed ID: 15807300 [TBL] [Abstract][Full Text] [Related]
12. Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson Disease. Tintner R; Manian P; Gauthier P; Jankovic J Arch Neurol; 2005 Aug; 62(8):1290-5. PubMed ID: 16087771 [TBL] [Abstract][Full Text] [Related]
13. [Low dose pergolide induced systemic edema and pleural effusion in a patient with Parkinson's disease]. Chihara N; Hayakawa M; Yoshimura M; Shiio Y; Nakase H Rinsho Shinkeigaku; 2008 Feb; 48(2):143-5. PubMed ID: 18326310 [TBL] [Abstract][Full Text] [Related]
14. [Retroperitoneal fibrosis secondary to treatment with L-dopa analogues for Parkinson disease]. Sánchez-Chapado M; Angulo Cuesta J; Guil Cid M; Jiménez FJ; López Alvarez YJ Arch Esp Urol; 1995 Dec; 48(10):979-83. PubMed ID: 8588730 [TBL] [Abstract][Full Text] [Related]